References
- MarkandONLennox-Gastaut syndrome (childhood epileptic encephalopathy)J Clin Neurophysiol20032042644114734932
- NabboutRDulacOEpileptic encephalopathies: A brief overviewJ Clin Neurophysiol20032039339714734929
- GuerriniREpilepsy in childrenLancet200636749952416473127
- ArzimanoglouAFrenchJBlumeWTLennox-Gastaut syndrome: A consensus approach on diagnosis, assessment, management, and trial methodologyLancet Neurol20098829319081517
- AicardiJLevy GomesAClinical and electroencephalographic symptomatology of the ‘genuine’ Lennox-Gastaut syndrome and its differentiation from other forms of epilepsy of early childhoodEpilepsy Res19926185193
- FitzgeraldLFStoneJLHughesJRThe Lennox-Gastaut syndrome: Electroencephalographic characteristics, clinical correlates, and follow-up studiesClin Encephalogr199223180189
- TrevathanEMurphyCCYeargin-AllsoppMPrevalence and descriptive epidemiology of Lennox-Gastaut Syndrome among Atlanta childrenEpilepsia199738128312889578523
- GentonPGuerrineRDravetCThe Lennox-Gastaut syndromeMeinardiHHandbook of Clinical Neurology: The Epilepsies, Part IIAmsterdamElsevier Science2000
- KlugerGBauerBRole of rufinamide in the management of Lennox-Gastaut syndrome (childhood epileptic encephalopathy)Neuropsychiatr Dis Treat2007331119300535
- BegleyCEFamulariMAnnegersJFThe cost of epilepsy in the United States: An estimate from population-based clinical and survey dataEpilepsia20004134235110714408
- RogerJDravetCBureauMThe Lennox-Gastaut syndromeCleve Clin J Med198956Suppl Pt 2S172S1802499428
- PanayiotopoulousCEpileptic encephalopathies infancy and early childhoodA Clinical Guide to Epileptic Syndromes and Their Treatment2nd edLondonSpringer2007
- FrenchJAThe role of new antiepileptic drugsAm J Manage Care.20077SupplS209S214
- GlauserTKlugerGSachdeoRRufinamide for generalized seizures associated with Lennox-Gastaut syndromeNeurology2008701950195818401024
- SchmidtDBourgeoisBA risk-benefit assessment of therapies for Lennox-Gastaut syndromeDrug Saf20002246747710877040
- No authors listedEfficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). The Felbamate Study Group in Lennox-Gastaut syndromeN Engl J Med199332829338347179
- MotteJTrevathanEArvidssonJFLamotrigine for generalised seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study GroupN Engl J Med1997337180718129400037
- SachdeoRCGlauserTARitterFA double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study GroupNeurology1999521882188710371538
- WhelessJWClarkeDFCarpenterDTreatment of pediatric epilepsy: Expert opinionJ Child Neurol200520Suppl 1S1S6016615562
- ConryJANgYTPaolicchiJMClobazam in the treatment of Lennox-Gastaut syndromeEpilepsia2009501158116619170737
- Johannessen LandmarkCJohannessenSIPharmacological management of epilepsy: Recent advances and future prospectsDrugs2008681925193918778117
- McCleanMJSchmutzMPozzaMThe influence of rufinamide on sodium currents and action potential firing in rodent neurons [Abstr]Epilepsia200546Suppl 73.062
- Banzel [Package insert].Woodruff Lake, NJEisai Inc12009
- HutchinsonDJLiouYBestRStability of extemporaneously prepared rufinamide oral suspensionsAnn Pharmacother20104446246520150505
- WaldmeierFGschwindH-PRouanM-CMetabolism of the new anticonvulsive drug rufinamide 9CGP 33101 in healthy male volunteers [Abstr]Epilepsia.199637Suppl 5167 6.60
- PeruccaECloydJCritchleyDRufinamide: Clinical pharmacokinetics and concentration-response relationships in patients with epilepsyEpilepsia2008491123114118503564
- CheungWKKianifardFWongAIntra- and inter-subject variabilities of CGP 33101 after replicate single oral doses of two 200- mg tablets and 400-mg suspensionPharm Res199512187818828786960
- BialerMJohannessenSIKupferbergHJProgress report on new antiepileptic drugs: A summary of the Fifth Eilat Conference (EILAT V)Epilepsy Res200143115811137386
- CritchleyDFuseauEPerdomoCPharmacokinetic and pharmacodynamic parameters of adjunctive rufinamide in patients with Lennox- Gastaut syndrome [Abstr]Epilepsia.200546Suppl 72.351
- FuseauECritchleyDPerdomoCPopulation pharmacokinetic drug-drug interaction analyses of rufinamide studies in patients with epilepsy [Abstr]Epilepsia.200546Suppl 82.356
- SvendsenKDChoiLChenBLSingle center, open-label, multiple-dose pharmacokinetic trial investigating the effect of rufinamide administration on Ortho-Novum 1/35 in healthy women [Abstr]Epilepsia.199839Suppl 659.2.111
- GlauserTKlugerGSachdeoROpen-label extension study of the efficacy and safety of rufinamide adjunctive therapy in patients with Lennox- Gastaut syndrome [Abstr 1356]Epilepsia200546Suppl 6408
- KraussGLPerdomoCArroyoSShort-term and long-term safety of rufinamide in patients with epilepsy [Abstr]Epilepsia200546Suppl 73.263
- WhelessJWConryJKraussGSafety and tolerability of rufinamide in children with epilepsy: A pooled analysis of seven clinical studiesJ Child Neurol2009241520152519955344
- BjerregaardPGussakIShort QT syndromeAnn Noninvasive Electrocardiol20051043644016255754
- KlugerGGlauserTKraussGAdjunctive rufinamide in Lennox- Gastaut syndrome: A long-term, open-label extension studyActa Neurol Scand312010 [Epub ahead of print]
- KlugerGKurlemannGHaberlandtEEffectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: First European experienceEpilepsy Behav20091449149519162229
- VerdianLYiYCost-utility analysis of rufinamide versus topiramate and lamotrigine for the treatment of children with Lennox-Gastaut syndrome in the United KingdomSeizure20101911119942457
- HancockECrossHTreatment of Lennox-Gastaut syndromeCochrane Database Syst Rev2003CD00327712917958